scholarly article | Q13442814 |
systematic review | Q1504425 |
review article | Q7318358 |
P2093 | author name string | J Villar | |
S H Kennedy | |||
C M Becker | |||
K E May | |||
S Kirtley | |||
P2860 | cites work | Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis. | Q54382675 |
Absence of aromatase protein and mRNA expression in endometriosis. | Q54479418 | ||
Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression. | Q54511836 | ||
Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium. | Q54523457 | ||
beta-HCG/LH receptor (beta-HCG/LH-R) expression in eutopic endometrium and endometriotic implants: evidence for beta-HCG sensitivity of endometriosis. | Q54527182 | ||
Glycodelin expression in the endometrium of healthy women and in the eutopic and ectopic endometrium of women with endometriosis. | Q54537706 | ||
Menstrual effluent in endometriosis shows no difference in volume, VEGF-A, MMP2 and MMP9 or sFLT. | Q54617825 | ||
Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. | Q54648896 | ||
mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay. | Q54690794 | ||
Expression of allograft inflammatory factor-1 in human eutopic endometrium and endometriosis: possible association with progression of endometriosis. | Q54695725 | ||
ESHRE guideline for the diagnosis and treatment of endometriosis | Q56627429 | ||
Epithelial cells in peritoneal fluid—of endometrial origin? | Q57578252 | ||
Apoptosis and proliferative activity in endometrium during peritoneal endometriosis | Q58616456 | ||
Proliferative Activity of Microvessels and Angiogenesis in Eutopic Endometrium in Patients with Peritoneal Endometriosis | Q58616460 | ||
Peripheral biomarkers of endometriosis: a systematic review | Q24632541 | ||
The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews | Q24801517 | ||
Augmented cell survival in eutopic endometrium from women with endometriosis: expression of c-myc, TGF-beta1 and bax genes | Q24815636 | ||
The macrophage stimulating protein/RON system: a potential novel target for prevention and treatment of endometriosis | Q28239560 | ||
Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection | Q28305759 | ||
Macrophage expression in endometrium of women with and without endometriosis | Q30854821 | ||
Post-translational modifications and protein-specific isoforms in endometriosis revealed by 2D DIGE. | Q30978574 | ||
DNA microarray analysis of gene expression in eutopic endometrium from patients with deep endometriosis using laser capture microdissection. | Q33224742 | ||
Genomic alterations in ectopic and eutopic endometria of women with endometriosis | Q33242598 | ||
Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis | Q33262536 | ||
An investigation of the effects of endometriosis on the proteome of human eutopic endometrium: a heterogeneous tissue with a complex disease | Q33264530 | ||
Laser capture microdissection and cDNA array analysis of endometrium identify CCL16 and CCL21 as epithelial-derived inflammatory mediators associated with endometriosis | Q33284841 | ||
Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis | Q33304163 | ||
Up-regulation of endocrine gland-derived vascular endothelial growth factor but not vascular endothelial growth factor in human ectopic endometriotic tissue | Q33398952 | ||
Differentially expressed genes in eutopic and ectopic endometrium of women with endometriosis | Q33406718 | ||
HOXA-10 expression in the mid-secretory endometrium of infertile patients with either endometriosis, uterine fibromas or unexplained infertility | Q33500721 | ||
Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis | Q33518252 | ||
Identification biomarkers of eutopic endometrium in endometriosis using artificial neural networks and protein fingerprinting | Q33521611 | ||
Impaired down-regulation of E-cadherin and beta-catenin protein expression in endometrial epithelial cells in the mid-secretory endometrium of infertile patients with endometriosis | Q33561532 | ||
Detection of mitochondrial biomarkers in eutopic endometria of endometriosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry | Q33631883 | ||
Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase | Q34268871 | ||
EMX2 gene expression in the female reproductive tract and aberrant expression in the endometrium of patients with endometriosis | Q34318724 | ||
Endometrial expression of relaxin and relaxin receptor in endometriosis | Q34336616 | ||
Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis | Q35746291 | ||
Endocrine regulation of menstruation | Q36256328 | ||
Endometrial pinopode and alphavbeta3 integrin expression is not impaired in infertile patients with endometriosis | Q36271248 | ||
Inflammatory status influences aromatase and steroid receptor expression in endometriosis. | Q36509755 | ||
lmmuno Histochemical Profile of Endometrium in Patients With Genital Endometriosis | Q36618583 | ||
Calpain5 expression is decreased in endometriosis and regulated by HOXA10 in human endometrial cells | Q37324405 | ||
MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis | Q37348044 | ||
Increased mitogen-activated protein kinase kinase/extracellularly regulated kinase activity in human endometrial stromal fibroblasts of women with endometriosis reduces 3',5'-cyclic adenosine 5'-monophosphate inhibition of cyclin D1. | Q37369106 | ||
The role of the Angiopoietins in vascular morphogenesis. | Q37486191 | ||
Diagnosis of endometriosis by detection of nerve fibres in an endometrial biopsy: a double blind study. | Q37582103 | ||
Increased leptin expression in endometriosis cells is associated with endometrial stromal cell proliferation and leptin gene up-regulation | Q38289502 | ||
Mechanisms regulating invasiveness and growth of endometriosis lesions in rat experimental model and in humans. | Q51593327 | ||
Prokineticin 1 mRNA expression in the endometrium of healthy women and in the eutopic endometrium of women with endometriosis. | Q51769691 | ||
"Spot"-ting differences between the ectopic and eutopic endometrium of endometriosis patients. | Q51778016 | ||
Density of small diameter sensory nerve fibres in endometrium: a semi-invasive diagnostic test for minimal to mild endometriosis. | Q51800477 | ||
Sustained replication in endometrium of women with endometriosis occurs without evoking a DNA damage response. | Q51944546 | ||
Immunohistochemical localization of granulocyte-macrophage colony-stimulating factor in matched endometriosis and endometrial tissues. | Q52882883 | ||
Expression of cyclooxygenase-2 in eutopic endometrium and ovarian endometriotic tissue in women with severe endometriosis. | Q53483229 | ||
P27Kip1 is down-regulated in the endometrium of women with endometriosis. | Q53494413 | ||
Endometrium from women with endometriosis shows increased proliferation activity. | Q53506433 | ||
Increased telomerase activity and human telomerase reverse transcriptase mRNA expression in the endometrium of patients with endometriosis. | Q53585468 | ||
Use of proteomic analysis of endometriosis to identify different protein expression in patients with endometriosis versus normal controls. | Q53619884 | ||
Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis. | Q53704918 | ||
Decreased apoptosis and sensitivity to macrophage mediated cytolysis of endometrial cells in endometriosis. | Q54104725 | ||
Differential expression of interleukins (IL)-13 and IL-15 in ectopic and eutopic endometrium of women with endometriosis and normal fertile women | Q38354330 | ||
HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium | Q38440107 | ||
Relationship between apoptosis and the number of macrophages in eutopic endometrium from women with and without endometriosis | Q38454936 | ||
Increased expression of endoglin in the eutopic endometrium of women with endometriosis | Q38458893 | ||
Angiopoietin-1, angiopoietin-2 and Tie-2 expression in eutopic endometrium in advanced endometriosis | Q38510096 | ||
Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium | Q38521873 | ||
Pleiotrophin (PTN) and midkine (MK) mRNA expression in eutopic and ectopic endometrium in advanced stage endometriosis | Q38523142 | ||
Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis | Q39890981 | ||
Proteomic analysis of protein expression in the eutopic endometrium of women with endometriosis | Q40169365 | ||
Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. | Q40330548 | ||
High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis | Q42485838 | ||
The depolarized expression of the alpha-6 integrin subunit in the endometria of women with endometriosis | Q42495317 | ||
c-fos gene and protein expression in pelvic endometriosis: a local marker of estrogen action. | Q42611588 | ||
Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy | Q43007232 | ||
Regulation of monocyte chemotactic protein-1 expression in human endometrial endothelial cells by sex steroids: a potential mechanism for leukocyte recruitment in endometriosis | Q43236806 | ||
Altered glycosylation in peri-implantation phase endometrium in women with stages III and IV endometriosis. | Q43243217 | ||
Endometriotic stromal cells lose the ability to regulate cell-survival signaling in endometrial epithelial cells in vitro | Q43291195 | ||
Xanthine oxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis | Q43564901 | ||
Hyperprolactinemia and luteal insufficiency in infertile patients with mild and minimal endometriosis. | Q43624762 | ||
Abnormal interleukin-1 receptor type II gene expression in the endometrium of women with endometriosis | Q43862728 | ||
Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis | Q44173807 | ||
Global gene analysis of late secretory phase, eutopic endometrium does not provide the basis for a minimally invasive test of endometriosis | Q44396145 | ||
Regulation of interleukin-8 expression in human endometrial endothelial cells: a potential mechanism for the pathogenesis of endometriosis | Q45197380 | ||
Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis. | Q46017599 | ||
Activin A, activin receptor type II, nodal, and cripto mRNA are expressed by eutopic and ectopic endometrium in women with ovarian endometriosis. | Q46040287 | ||
Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism | Q46195129 | ||
Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis | Q46212864 | ||
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness | Q46257564 | ||
Extracellularly signal-regulated kinase activity in the human endometrium: possible roles in the pathogenesis of endometriosis | Q46535440 | ||
Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length. | Q46611870 | ||
High expression levels of cyclin B1 and Polo-like kinase 1 in ectopic endometrial cells associated with abnormal cell cycle regulation of endometriosis | Q46692478 | ||
Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis. | Q46843647 | ||
Androgen receptor and 5alpha-reductase are expressed in pelvic endometriosis. | Q46914102 | ||
Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers | Q46968715 | ||
Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients | Q46987386 | ||
Quantitative expression of apoptosis-regulating genes in endometrium from women with and without endometriosis | Q47586464 | ||
Deficient Expression of Tumor Necrosis Factor Receptor Type 2 in the Endometrium of Women with Endometriosis | Q47609055 | ||
Expression of oestrogen receptor-alpha splicing variants and oestrogen receptor-beta in endometrium of infertile patients | Q47694721 | ||
Anti-apoptotic and pro-apoptotic gene expression evaluated from eutopic endometrium in the proliferative phase of the menstrual cycle among women with endometriosis and healthy controls | Q47729667 | ||
Vascular endothelial growth factor (VEGF) in endometriosis | Q47750518 | ||
Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants | Q47983467 | ||
Endometrial vascular and glandular expression of integrin alpha(v)beta3 in women with and without endometriosis | Q47996307 | ||
Iron overload in the peritoneal cavity of women with pelvic endometriosis. | Q50498020 | ||
Transcriptional expression of survivin and its splice variants in endometriosis. | Q50736061 | ||
Acceptability and pain of outpatient hysteroscopy. | Q51421090 | ||
Patient's acceptance of outpatient hysteroscopy. | Q51468952 | ||
Low prevalence of DNA viruses in the human endometrium and endometriosis. | Q51576581 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systematic review | Q1504425 |
endometriosis | Q205764 | ||
biomarker | Q864574 | ||
P304 | page(s) | 637-53 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | Human Reproduction Update | Q15724523 |
P1476 | title | Endometrial alterations in endometriosis: a systematic review of putative biomarkers | |
P478 | volume | 17 |
Q39479395 | Aberrant Endometrial DNA Methylome and Associated Gene Expression in Women with Endometriosis |
Q35449469 | Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosis |
Q34324798 | An update on the pharmacological management of endometriosis |
Q34283752 | Antioxidant supplementation reduces endometriosis-related pelvic pain in humans |
Q38953005 | Are endometrial nerve fibres unique to endometriosis? A prospective case-control study of endometrial biopsy as a diagnostic test for endometriosis in women with pelvic pain |
Q46564649 | Beyond Body Mass Index: Using Anthropometric Measures and Body Composition Indicators to Assess Odds of an Endometriosis Diagnosis |
Q38235997 | Biomarker development in endometriosis |
Q38600873 | CCL19/CCR7 contributes to the pathogenesis of endometriosis via PI3K/Akt pathway by regulating the proliferation and invasion of ESCs |
Q61797208 | CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis |
Q58758995 | Clinical evaluation and management of endometriosis: guideline for Korean patients from Korean Society of Endometriosis |
Q26470966 | Combination of the non-invasive tests for the diagnosis of endometriosis |
Q47732045 | Decoy receptor 3 promotes cell adhesion and enhances endometriosis development. |
Q26823337 | Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis In Montpellier, France |
Q36920911 | Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study |
Q35902110 | Diagnostic accuracy of urinary cytokeratin 19 fragment for endometriosis |
Q38365392 | Diagnostic potential of peritoneal fluid biomarkers of endometriosis |
Q38179305 | ESHRE guideline: management of women with endometriosis. |
Q45326960 | Endometrial assessment: a clinical guide |
Q24185846 | Endometrial biomarkers for the non-invasive diagnosis of endometriosis |
Q39365130 | Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why. |
Q57175383 | Endometriosis |
Q37648048 | Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment |
Q49584912 | Endometriosis: Epidemiology, Diagnosis and Clinical Management. |
Q56505755 | Estimating Omissions From Searches |
Q45048686 | Estrogen stabilizes hypoxia-inducible factor 1α through G protein-coupled estrogen receptor 1 in eutopic endometrium of endometriosis |
Q28583414 | Extracts of Salvia miltiorrhiza Bunge on the cytokines of rat endometriosis models |
Q37616938 | Extrapelvic endometriosis: a rare entity or an under diagnosed condition? |
Q92593733 | GLI1 is increased in ovarian endometriosis and regulates migration, invasion and proliferation of human endometrial stromal cells in endometriosis |
Q35112893 | Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis. |
Q27012789 | Guidelines for the design, analysis and interpretation of 'omics' data: focus on human endometrium |
Q36423105 | High temperature requirement A1, transforming growth factor beta1, phosphoSmad2 and Ki67 in eutopic and ectopic endometrium of women with endometriosis. |
Q33742095 | Identification of global transcriptome abnormalities and potential biomarkers in eutopic endometria of women with endometriosis: A preliminary study |
Q46617962 | Interleukin-6, intracellular adhesion molecule-1, and glycodelin A levels in serum and peritoneal fluid as biomarkers for endometriosis. |
Q38152232 | Mechanism of pain generation for endometriosis-associated pelvic pain |
Q35100176 | Metabolite Profiling in the Pursuit of Biomarkers for IVF Outcome: The Case for Metabolomics Studies |
Q30409164 | Molecular classification of endometriosis and disease stage using high-dimensional genomic data |
Q91272411 | Multiplex analysis of 40 cytokines do not allow separation between endometriosis patients and controls |
Q37996102 | New treatment strategies and emerging drugs in endometriosis |
Q38197676 | Noninvasive biomarkers of endometriosis: myth or reality? |
Q35944436 | Overall Adiposity, Adipose Tissue Distribution, and Endometriosis: A Systematic Review |
Q24596679 | Pathogenesis and pathophysiology of endometriosis |
Q26801594 | Pathophysiology and Immune Dysfunction in Endometriosis |
Q34421299 | Peripheral changes in endometriosis-associated pain |
Q37069250 | Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis |
Q54318193 | Possible involvement of the E-cadherin gene in genetic susceptibility to endometriosis. |
Q39354593 | Pregnancy outcome in women with endometriosis achieving pregnancy with IVF. |
Q33711866 | Primiparous singleton women with endometriosis have an increased risk of preterm birth: Meta-analyses. |
Q90089561 | Protocol for a longitudinal, prospective cohort study investigating the biology of uterine fibroids and endometriosis, and patients' quality of life: the FENOX study |
Q38821229 | Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives |
Q46565764 | Research Priorities for Endometriosis |
Q64065096 | Serum concentrations of CCL20/MIP-3alpha in women with endometriosis |
Q34171341 | Sprouted innervation into uterine transplants contributes to the development of hyperalgesia in a rat model of endometriosis |
Q46840635 | Src as a novel therapeutic target for endometriosis |
Q54279484 | Stretch magnitude- and frequency-dependent cyclooxygenase 2 and prostaglandin E2 up-regulation in human endometrial stromal cells: possible implications in endometriosis. |
Q37694941 | Survivin and VEGF as Novel Biomarkers in Diagnosis of Endometriosis. |
Q92715957 | Technical Verification and Assessment of Independent Validation of Biomarker Models for Endometriosis |
Q28082175 | The Impact of Endometriosis across the Lifespan of Women: Foreseeable Research and Therapeutic Prospects |
Q36854749 | The Serum Levels of the Soluble Factors sCD40L and CXCL1 Are Not Indicative of Endometriosis |
Q50592781 | The Targeted Delivery of Interleukin 4 Inhibits Development of Endometriotic Lesions in a Mouse Model. |
Q39064220 | The oil-resin of the tropical rainforest tree Copaifera langsdorffii reduces cell viability, changes cell morphology and induces cell death in human endometriotic stromal cultures |
Q24564121 | The role of lipoxin A4 in endometrial biology and endometriosis |
Q59046724 | Theories on the pathogenesis of endometriosis |
Q38133821 | Towards an understanding of the molecular mechanism of endometriosis: unbalancing epithelial-stromal genetic conflict. |
Q26799195 | Update on Biomarkers for the Detection of Endometriosis |
Q64998539 | Women with Endometriosis, Especially Those Who Conceived with Assisted Reproductive Technology, Have Increased Risk of Placenta Previa: Meta-analyses. |
Q50631912 | Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome. |
Q30844378 | World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: I. Surgical phenotype data collection in endometriosis research |
Q26827259 | World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis research |
Q39069095 | p27kip1 overexpression regulates VEGF expression, cell proliferation and apoptosis in cell culture from eutopic endometrium of women with endometriosis. |